biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > Cannacord...

<< Previous

Bullboard Posts

Next >>

Post by fishtailon Jan 18, 2021 5:40pm

250 Views

Post# 32322714

Cannacord...

Hmmm

where do we go from here...

House Positions for C:BTI from 20210118 to 20210118

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
33 Canaccord	102,000	47,720	0.468	21,000	10,905	0.519	81,000	-36,815
85 Scotia	46,500	22,195	0.477	35,000	15,850	0.453	11,500	-6,345
79 CIBC	7,500	3,490	0.465	0			7,500	-3,490
59 PI	500	230	0.46	0			500	-230
7 TD Sec	38,800	18,214	0.469	50,100	23,834	0.476	-11,300	5,620
1 Anonymous	73,000	37,670	0.516	116,000	56,040	0.483	-43,000	18,370
2 RBC	0			46,200	22,890	0.495	-46,200	22,890
TOTAL	268,300	129,519	0.483	268,300	129,519	0.483	0	0